NKX2-1 and neoplasm: In neuroendocrine prostate cancer, NKX2-1 acts as a key transcriptional driver that upregulates serine/glycine synthesis enzymes, thereby reprogramming cellular metabolism to support proliferation, invasion, and overall tumor aggressiveness under nutrient‐limited conditions (44).